Wall Street is struggling amid AI overvaluation fears, as well as warnings from chief executives at Morgan Stanley (MS) and Goldman Sachs (GS) of an up to 20% equity market pullback in the next one to two years.
PERRYSBURG, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Stable Top-line With Significantly Higher Margins and Earnings Continued Strong Fit To Win Execution Drives Upgraded 2025 Earnings Guidance O-I Glass, Inc. (“O-I”) (NYSE: OI) today reported financial results for the third quarter ended September 30, 2025. Net Earnings (Loss) Attributable to the Company Per Share (Diluted) Earnings (Loss) Before Income Taxes $M 3Q25 3Q24 3Q25 3Q24 Reported $ 0.19 ($0.52) $58 (margins up 690 basis points) ($ 57 ) Adjusted Earnings (Loss) Earnings Per Share (Diluted) Segment Operating Profit $M 3Q25 3Q24 3Q25 3Q24 Non – GAAP $ 0.48 ($0.04) $235 (margins up 570 basis points) $ 144 “O-I delivered strong third-quarter earnings along with substantially higher margins compared to the prior year period.
MCLEAN, VA / ACCESS Newswire / November 4, 2025 / Gladstone Investment Corporation (Nasdaq: GAIN) (the "Company") today announced earnings for its second fiscal quarter ended September 30, 2025. Please read the Company's Quarterly Report on Form 10-Q, filed today with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov or the investors section of the Company's website at www.gladstoneinvestment.com.
Palantir's stock fell sharply on Tuesday despite upbeat earnings, while its CEO criticized short sellers.
Notable duopolies have emerged in fast food, with McDonald's NYSE: MCD and Burger King becoming the iconic brands. Starbucks NASDAQ: SBUX and Dunkin rule the coffee landscape, and Nike NYSE: NKE and Adidas OTCMKTS: ADDDF are at the forefront of athletic apparel and footwear.
DALLAS , Nov. 4, 2025 /PRNewswire/ -- The Board of Directors of Comerica Incorporated (NYSE: CMA) declared a quarterly cash dividend for common stock of 71 cents ($0.71) per share. The dividend is payable Jan. 1, 2026, to shareholders of record at the close of business on Dec. 15, 2025.
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2025.
Corebridge Financial, Inc. ( CRBG ) Q3 2025 Earnings Call November 4, 2025 10:00 AM EST Company Participants Isil Muderrisoglu - Head of Investor & Rating Agency Relations Kevin Hogan - President, CEO & Director Elias Habayeb - Executive VP & CFO Conference Call Participants Joel Hurwitz - Dowling & Partners Securities, LLC Taylor Scott - Barclays Bank PLC, Research Division Thomas Gallagher - Evercore ISI Institutional Equities, Research Division Francis Matten - BMO Capital Markets Equity Research Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Elyse Greenspan - Wells Fargo Securities, LLC, Research Division Suneet Kamath - Jefferies LLC, Research Division Cave Montazeri - Deutsche Bank AG, Research Division Wesley Carmichael - Autonomous Research US LP Presentation Operator Hello, and welcome, everyone, to the Corebridge Financial Third Quarter 2025 Earnings Call. My name is Becky, and I'll be your operator today.
Franco-Nevada Corporation ( FNV:CA ) Q3 2025 Earnings Call November 4, 2025 11:00 AM EST Company Participants Candida Hayden - IR Contact Paul Brink - President, CEO & Director Sandip Rana - Chief Financial Officer Eaun Gray - Chief Investment Officer Conference Call Participants Fahad Tariq - Jefferies LLC, Research Division Sathish Kasinathan - BofA Securities, Research Division Case Bongirne - H.C. Wainwright & Co, LLC, Research Division Cosmos Chiu - CIBC Capital Markets, Research Division Tanya Jakusconek - Scotiabank Global Banking and Markets, Research Division John Tumazos - John Tumazos Very Independent Research, LLC Daniel Major - UBS Investment Bank, Research Division Derick Ma - TD Cowen, Research Division Presentation Operator Good morning, and welcome to Franco-Nevada Corporation's Third Quarter 2025 Results Conference Call.
Zoetis Inc. ( ZTS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Steven Frank - Vice President of Investor Relations Kristin Peck - CEO & Director Wetteny Joseph - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Michael Ryskin - BofA Securities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division Andrea Zayco Narvaez Alfonso - UBS Investment Bank, Research Division Presentation Operator Good morning, everyone, and welcome to the Third Quarter 2025 Financial Results Conference Call and Webcast for Zoetis.
Kyndryl Holdings reported a slight drop in second-quarter revenue on Tuesday, as the former IBM unit works to reduce and renegotiate inherited contracts that have hampered margins.
Unum Group ( UNM ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants J. Royal - Senior Vice President of Investor Relations & Treasury Richard McKenney - President, CEO & Director Steven Zabel - Executive VP & CFO Christopher Pyne - Executive Vice President of Group Benefits Timothy Arnold - Executive VP of Voluntary Benefits & President of Colonial Life Mark Till - Executive VP & CEO of Unum International Conference Call Participants Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Thomas Gallagher - Evercore ISI Institutional Equities, Research Division Joel Hurwitz - Dowling & Partners Securities, LLC Elyse Greenspan - Wells Fargo Securities, LLC, Research Division Taylor Scott - Barclays Bank PLC, Research Division Suneet Kamath - Jefferies LLC, Research Division Francis Matten - BMO Capital Markets Equity Research Wilma Jackson Burdis - Raymond James & Associates, Inc., Research Division Wesley Carmichael - Autonomous Research US LP Tracy Benguigui - Wolfe Research, LLC Maxwell Fritscher - Truist Securities, Inc., Research Division Joshua Shanker - BofA Securities, Research Division Presentation Operator Hello and thank you for standing by.
National Storage Affiliates Trust ( NSA ) Q3 2025 Earnings Call November 4, 2025 1:00 PM EST Company Participants George Hoglund - Vice President of Investor Relations David Cramer - President, CEO & Trustee Brandon Togashi - Executive VP, CFO & Treasurer Conference Call Participants Samir Khanal - BofA Securities, Research Division Michael Goldsmith - UBS Investment Bank, Research Division Spenser Allaway - Green Street Advisors, LLC, Research Division Eric Wolfe - Citigroup Inc., Research Division Michael Griffin - Evercore ISI Institutional Equities, Research Division Juan Sanabria - BMO Capital Markets Equity Research Todd Thomas - KeyBanc Capital Markets Inc., Research Division Jonathan Petersen - Jefferies LLC, Research Division Ravi Vaidya - Mizuho Securities USA LLC, Research Division Brendan Lynch - Barclays Bank PLC, Research Division Ronald Kamdem - Morgan Stanley, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Greetings. Welcome to the National Storage Affiliates' Third Quarter 2025 Conference Call.
NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) today reported financial results for the third quarter ended September 30, 2025. “AIG had an exceptional third quarter. We successfully executed on multiple complex strategic transactions to further position AIG for the future while also delivering outstanding financial results,” said Peter Zaffino, AIG Chairman & Chief Executive Officer. “Last week, we announced investments in Convex Group, a global specialty insurer.
Match Group forecast fourth-quarter revenue below analysts' estimates on Tuesday, underscoring ongoing challenges in its turnaround efforts as the Tinder parent struggles to convert casual swipers into loyal, paying users.
Tesla, Inc. warrants a fresh valuation approach as new catalysts—lower-priced models and Q3 updates—drive a strong share price rally. Adaptation of new technologies has largely followed a 10-10 rule (10 years to build and another 10 for mass penetration). Recent exponential growth in TSLA's autonomous driving miles and updates on futuristic technologies could allow TSLA to break the typical 20-year tech adoption cycle.
Tesla's third-quarter earnings were a surprise miss, with profits taking a steep plunge after the company cut car prices to increase sales. But CEO Elon Musk told investors he wants to be back in the driver's seat.
LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Third Quarter Financial Highlights On November 4, 2025, the Board of Directors of Navigator Holdings Ltd., (NYSE: NVGS) (“Navigator Holdings”, “Navigator Gas”, “our”, “we”, “us” or the “Company”) approved a revision to the Company's existing capital return policy first announced in May 2023 (the "Revised Capital Return Policy").
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026 Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on track for Nov./Dec. 2025 Phase 2b data for rosnilimab in rheumatoid arthritis featured as late-breaking oral presentation at ACR Convergence 2025 Phase 1b initiated in celiac disease for ANB033, a CD122 antagonist; top-line Phase 1b data anticipated in Q4 2026 GSK announced strong commercial performance for Jemperli, growing >16% quarter-over-quarter to $303 million in Q3 2025 and $785 million YTD 2025 Anaptys anticipates accruing a one-time $75 million commercial sales milestone in Q4 2025 from GSK once Jemperli achieves $1 billion in worldwide net sales >$390 million in annualized Jemperli royalties payable to Anaptys at GSK's peak sales guidance of >$2.7 billion, which Anaptys expects to be achieved before 2031 SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the third quarter ended September 30, 2025, and provided a business update. “Our intent to separate our wholly owned biopharma programs from our royalty assets provides investors with the opportunity to realize and enhance the potential value of two distinct sets of assets.
RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE: HIW) (the “Company”) announced today that Highwoods Realty Limited Partnership, the operating partnership through which the Company conducts its operations, has priced a $350 million offering of 5.350% unsecured notes under its existing shelf registration statement. The notes are due January 15, 2033 and were priced to yield 5.431%. The offering is expected to close on November 14, 2025, subject to the satisfaction of customary closing conditions.